BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34844636)

  • 1. Tracing TET1 expression in prostate cancer: discovery of malignant cells with a distinct oncogenic signature.
    Schagdarsurengin U; Luo C; Slanina H; Sheridan D; Füssel S; Böğürcü-Seidel N; Gattenloehner S; Baretton GB; Hofbauer LC; Wagenlehner F; Dansranjav T
    Clin Epigenetics; 2021 Nov; 13(1):211. PubMed ID: 34844636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol inhibits the tumor migration and invasion by upregulating TET1 and reducing TIMP2/3 methylation in prostate carcinoma cells.
    Wang K; Chen Z; Shi J; Feng Y; Yu M; Sun Y; Zhuang Q; Liang B; Luo G; Xu X; Fan M
    Prostate; 2020 Sep; 80(12):977-985. PubMed ID: 32542727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and epigenomic analysis of high-risk prostate cancer reveals changes in hydroxymethylation and TET1.
    Spans L; Van den Broeck T; Smeets E; Prekovic S; Thienpont B; Lambrechts D; Karnes RJ; Erho N; Alshalalfa M; Davicioni E; Helsen C; Gevaert T; Tosco L; Haustermans K; Lerut E; Joniau S; Claessens F
    Oncotarget; 2016 Apr; 7(17):24326-38. PubMed ID: 27014907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dysregulation of DNA epigenetic modulators during prostate carcinogenesis in an eastern Indian patient population: Prognostic implications.
    Banerjee A; Bardhan A; Sarkar P; Datta C; Pal DK; Saha A; Ghosh A
    Pathol Res Pract; 2024 Jan; 253():154970. PubMed ID: 38056136
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alterations of regulatory factors and DNA methylation pattern in thyroid cancer.
    Iancu IV; Botezatu A; Plesa A; Huica I; Fudulu A; Albulescu A; Bostan M; Mihaila M; Grancea C; Manda DA; Dobrescu R; Vladoiu SV; Anton G; Badiu CV
    Cancer Biomark; 2020; 28(2):255-268. PubMed ID: 32390600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MiR-183-5p promotes migration and invasion of prostate cancer by targeting TET1.
    Feng Y; Wang K; Qin M; Zhuang Q; Chen Z
    BMC Urol; 2023 Jul; 23(1):116. PubMed ID: 37430206
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TET1 upregulation drives cancer cell growth through aberrant enhancer hydroxymethylation of HMGA2 in hepatocellular carcinoma.
    Shirai K; Nagae G; Seki M; Kudo Y; Kamio A; Hayashi A; Okabe A; Ota S; Tsutsumi S; Fujita T; Yamamoto S; Nakaki R; Kanki Y; Osawa T; Midorikawa Y; Tateishi K; Ichinose M; Aburatani H
    Cancer Sci; 2021 Jul; 112(7):2855-2869. PubMed ID: 33970549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases.
    Hsu CH; Peng KL; Kang ML; Chen YR; Yang YC; Tsai CH; Chu CS; Jeng YM; Chen YT; Lin FM; Huang HD; Lu YY; Teng YC; Lin ST; Lin RK; Tang FM; Lee SB; Hsu HM; Yu JC; Hsiao PW; Juan LJ
    Cell Rep; 2012 Sep; 2(3):568-79. PubMed ID: 22999938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of ten-eleven translocation 1 (TET1) expression as a diagnostic and prognostic biomarker of endometrial carcinoma.
    Liu NT; Perng CL; Chou YC; Ko PS; Lin YJ; Lin YC; Chang CC; Wang YC; Shang HS; Chao TK
    PLoS One; 2021; 16(11):e0259330. PubMed ID: 34731191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential expression of ten-eleven translocation genes in endometrial cancers.
    Ciesielski P; Jóźwiak P; Wójcik-Krowiranda K; Forma E; Cwonda Ł; Szczepaniec S; Bieńkiewicz A; Bryś M; Krześlak A
    Tumour Biol; 2017 Mar; 39(3):1010428317695017. PubMed ID: 28349832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. TET1-Mediated Hypomethylation Activates Oncogenic Signaling in Triple-Negative Breast Cancer.
    Good CR; Panjarian S; Kelly AD; Madzo J; Patel B; Jelinek J; Issa JJ
    Cancer Res; 2018 Aug; 78(15):4126-4137. PubMed ID: 29891505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. TET1-mediated DNA hydroxymethylation activates inhibitors of the Wnt/β-catenin signaling pathway to suppress EMT in pancreatic tumor cells.
    Wu J; Li H; Shi M; Zhu Y; Ma Y; Zhong Y; Xiong C; Chen H; Peng C
    J Exp Clin Cancer Res; 2019 Aug; 38(1):348. PubMed ID: 31399111
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of ten-eleven translocation 1 (Tet1) on DNA methylation and gene expression in chicken primordial germ cells.
    Yu M; Li D; Cao W; Chen X; Du W
    Reprod Fertil Dev; 2019 Mar; 31(3):509-520. PubMed ID: 30282572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of TET dioxygenases in seminomas associates with low levels of DNA methylation and hydroxymethylation.
    Benešová M; Trejbalová K; Kučerová D; Vernerová Z; Hron T; Szabó A; Amouroux R; Klézl P; Hajkova P; Hejnar J
    Mol Carcinog; 2017 Aug; 56(8):1837-1850. PubMed ID: 28218476
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MYC deregulates TET1 and TET2 expression to control global DNA (hydroxy)methylation and gene expression to maintain a neoplastic phenotype in T-ALL.
    Poole CJ; Lodh A; Choi JH; van Riggelen J
    Epigenetics Chromatin; 2019 Jul; 12(1):41. PubMed ID: 31266538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. TET1 inhibits gastric cancer growth and metastasis by PTEN demethylation and re-expression.
    Pei YF; Tao R; Li JF; Su LP; Yu BQ; Wu XY; Yan M; Gu QL; Zhu ZG; Liu BY
    Oncotarget; 2016 May; 7(21):31322-35. PubMed ID: 27121319
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mono-ADP-ribosylation of H3R117 traps 5mC hydroxylase TET1 to impair demethylation of tumor suppressor gene TFPI2.
    Li M; Tang Y; Li Q; Xiao M; Yang Y; Wang Y
    Oncogene; 2019 May; 38(18):3488-3503. PubMed ID: 30651599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. FAM20C could be targeted by TET1 to promote odontoblastic differentiation potential of human dental pulp cells.
    Li Q; Yi B; Feng Z; Meng R; Tian C; Xu Q
    Cell Prolif; 2018 Apr; 51(2):e12426. PubMed ID: 29277934
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ten-eleven translocation 1 (TET1) gene is a potential target of miR-21-5p in human colorectal cancer.
    Cheng YW; Chou CJ; Yang PM
    Surg Oncol; 2018 Mar; 27(1):76-81. PubMed ID: 29549908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Oncogenic EGFR Represses the TET1 DNA Demethylase to Induce Silencing of Tumor Suppressors in Cancer Cells.
    Forloni M; Gupta R; Nagarajan A; Sun LS; Dong Y; Pirazzoli V; Toki M; Wurtz A; Melnick MA; Kobayashi S; Homer RJ; Rimm DL; Gettinger SJ; Politi K; Dogra SK; Wajapeyee N
    Cell Rep; 2016 Jul; 16(2):457-471. PubMed ID: 27346347
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.